Acceptability of a ‘treat to target’ approach in inflammatory bowel disease to patients in clinical remission

BACKGROUND: A ‘treat to target’ approach aiming for remission of clinical symptoms and absence of mucosal inflammation has been proposed in inflammatory bowel disease (IBD). We aimed to establish whether patients with IBD in clinical remission find this approach acceptable. METHODS: Patients in gluc...

Descripción completa

Detalles Bibliográficos
Autores principales: Selinger, Christian, Carbonell, Jenelyn, Kane, John, Omer, Mandour, Ford, Alexander Charles
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2020
Materias:
Colorectal
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7802490/
https://www.ncbi.nlm.nih.gov/pubmed/33493249
http://dx.doi.org/10.1136/flgastro-2019-101366

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7802490/
https://www.ncbi.nlm.nih.gov/pubmed/33493249
http://dx.doi.org/10.1136/flgastro-2019-101366

Ejemplares similares